Daily MDOI Identifier Registry
Browse, search, and export all registered MDOI identifiers. Use the filters below to narrow results.
1157 total identifiers
| # | Identifier | Title | Resource type | Visibility | Registered | Modified |
|---|---|---|---|---|---|---|
| 551 | 110.0645/CON.2026.00617 | A Taxonomy of Generative Artificial Intelligence in Health Economics and Outcomes Research: An ISPOR Working Group Report |
Article | Public | 2026-07-16 | 2026-07-16 |
| 552 | 110.0644/CON.2026.00616 | Provider Differences in Costs, Utilization, and Quality of Primary Care for Traumatic Brain Injury in the Military |
Article | Public | 2026-07-16 | 2026-07-16 |
| 553 | 110.0643/CON.2026.00615 | Economic Evaluation of the HEARTS Standardized Hypertension Treatment Program With Fixed-Dose Combination Pills in Chile Primary Care Clinics |
Article | Public | 2026-07-16 | 2026-07-16 |
| 554 | 110.0642/CON.2026.00614 | Comprehensive Access to Semaglutide: Clinical and Economic Implications for Medicare |
Article | Public | 2026-07-16 | 2026-07-16 |
| 555 | 110.0641/CON.2026.00613 | Cost-Effectiveness of Long-Chain Omega-3 Supplementation for the Secondary Prevention of Cardiovascular Disease in the United States |
Article | Public | 2026-07-16 | 2026-07-16 |
| 556 | 110.0640/CON.2026.00612 | Achieving Patient-Centered Value/Health Technology Assessment: Recommendations From a Multistakeholder eDelphi Panel |
Article | Public | 2026-07-16 | 2026-07-16 |
| 557 | 110.0639/CON.2026.00611 | Achieving Patient-Centered Value/Health Technology Assessment: Recommendations From a Multistakeholder eDelphi Panel |
Article | Public | 2026-07-16 | 2026-07-16 |
| 558 | 110.0638/CON.2026.00610 | Cost per Opioid-Free Year: A Systematic Review and Summary Analysis |
Article | Public | 2026-07-16 | 2026-07-16 |
| 559 | 110.0637/CON.2026.00609 | Utility Studies in Rare Diseases: A Systematic Literature Review |
Article | Public | 2026-07-16 | 2026-07-16 |
| 560 | 110.0636/CON.2026.00608 | Do We Always Need a New Preference Study? A Scoping Review of Promising Research Areas for Meta-Analyses and Benefit Transfers of Patient Preference Studies |
Article | Public | 2026-07-16 | 2026-07-16 |
| 561 | 110.0635/CON.2026.00607 | Quality of Care for Patients With Advanced Illness Scale: Development, Preference Elicitation, and Evaluation of Measurement Properties |
Article | Public | 2026-07-16 | 2026-07-16 |
| 562 | 110.0634/CON.2026.00606 | Health State Utilities for Achondroplasia: A Time Trade-Off Study |
Article | Public | 2026-07-16 | 2026-07-16 |
| 563 | 110.0633/CON.2026.00605 | Is There a General Preference for the Worse Off? A Discrete Choice Experiment Using Individually Calibrated Health State Valuations |
Article | Public | 2026-07-16 | 2026-07-16 |
| 564 | 110.0632/CON.2026.00604 | Comparisons of Preferences Toward EQ-5D-Y-3L Health States Between Adult Own and Child Perspectives |
Article | Public | 2026-07-16 | 2026-07-16 |
| 565 | 110.0631/CON.2026.00603 | Validity of the EQ-5D-5L for Routine Assessment in Residential Aged Care: Results From a Feasibility Study |
Article | Public | 2026-07-16 | 2026-07-16 |
| 566 | 110.0630/CON.2026.00602 | Building Blocks of Value Creation Within Value-Based Health Systems: A Delphi Study |
Article | Public | 2026-07-16 | 2026-07-16 |
| 567 | 110.0629/CON.2026.00601 | Use and Potential Misuse of Glucagon-Like Peptide-1 Receptor Agonists in France: A Nationwide Cohort Study |
Article | Public | 2026-07-16 | 2026-07-16 |
| 568 | 110.0626/CON.2026.00600 | Using Machine Learning to Match Clients and Therapy Providers: Evaluating Clinical Quality and Cost of Care |
Article | Public | 2026-07-14 | 2026-07-16 |
| 569 | 110.0625/CON.2026.00599 | The Cost-Effectiveness of an Artificial Intelligence-Based Population-Wide Screening Program for Primary Open-Angle Glaucoma in The Netherlands |
Article | Public | 2026-07-14 | 2026-07-16 |
| 570 | 110.0624/CON.2026.00598 | Synergizing Needs Assessments and Patient Preference Studies for Enhanced Patient-Centered Decision Making in Healthcare |
Article | Public | 2026-07-14 | 2026-07-14 |
| 571 | 110.0623/CON.2026.00597 | Psychometric Properties of the Modified EQ Health and Wellbeing and its Shorter Version in a General Chinese Population: A Comparative Analysis With EQ-5D-5L, SF-6Dv2, ICEpop CAPability measure for Adults, Short Version of Warwick-Edinburgh Mental Wellbeing Scale, and World Health Organization Well-Being Index 5-Item |
Article | Public | 2026-07-14 | 2026-07-14 |
| 572 | 110.0622/CON.2026.00596 | Understanding the Transition Between Age-Specific Measures of Health-Related Quality of Life: Evidence on the Relationship Between and Comparative Performance of the EQ-5D-Y-5L and EQ-5D-5L |
Article | Public | 2026-07-14 | 2026-07-14 |
| 573 | 110.0621/CON.2026.00595 | The Psychometric Performance of the EQ Health and Wellbeing in Caregivers of Persons Living With Dementia |
Article | Public | 2026-07-14 | 2026-07-14 |
| 574 | 110.0620/CON.2026.00594 | Mapping EQ-5D-5L Utilities in Dementia: Integrating Self and Proxy Reports |
Article | Public | 2026-07-14 | 2026-07-14 |
| 575 | 110.0619/CON.2026.00593 | Exemption System for Economic Evaluation Data Submission for Pharmaceuticals in South Korea: Achievements and Challenges |
Article | Public | 2026-07-14 | 2026-07-14 |
| 576 | 110.0618/CON.2026.00592 | Costs and Outcomes After Primary and Revision Hip Replacements by Implant Bearing Materials: Analysis of 550 760 linked Patient Records from English Routinely Collected Databases |
Article | Public | 2026-07-14 | 2026-07-14 |
| 577 | 110.0617/CON.2026.00591 | The Burden of Mitochondrial Disease: Healthcare and Societal Costs |
Article | Public | 2026-07-14 | 2026-07-14 |
| 578 | 110.0616/CON.2026.00590 | Statistical Methods for Analyzing EQ-5D in Randomized Clinical Trials: A Systematic Literature Review |
Article | Public | 2026-07-14 | 2026-07-14 |
| 579 | 110.0615/CON.2026.00589 | A Scoping Review of Interventions to Reduce the Environmental Footprint of Healthcare |
Article | Public | 2026-07-14 | 2026-07-14 |
| 580 | 110.0614/CON.2026.00588 | The Role of Mental Health in Healthcare Choices: A Discrete Choice Experiment Examining Preferences for Primary Care |
Article | Public | 2026-07-14 | 2026-07-14 |
| 581 | 110.0613/CON.2026.00587 | Mapping the Kidney Disease Quality-of-Life Questionnaire Onto the EQ-5D-5L Utility Index in Patients Undergoing Hemodialysis |
Article | Public | 2026-07-13 | 2026-07-14 |
| 582 | 110.0612/CON.2026.00586 | Psychometric Performance of a New Condition-Specific Preference-Weighted Measure, Vision Impairment in Low Luminance-Utility Index, and EQ-5D-5L in Patients With Age-Related Macular Degeneration: A MACUSTAR Study Report |
Article | Public | 2026-07-13 | 2026-07-14 |
| 583 | 110.0611/CON.2026.00585 | Psychometric Evaluation of the Proxy-Reported Pediatric Quality of Life Inventory Generic Core Scales Across the Childhood Lifespan in Australian Children and Adolescents With Specified Health Conditions |
Article | Public | 2026-07-13 | 2026-07-13 |
| 584 | 110.0610/CON.2026.00584 | Identifying the Influential Dynamic Inputs in Cost-Effectiveness Analyses |
Article | Public | 2026-07-13 | 2026-07-13 |
| 585 | 110.0609/CON.2026.00583 | Stakeholder Views on the Use and Challenges of Using Early Economic Evaluations in Health Innovation Development in The Netherlands |
Article | Public | 2026-07-13 | 2026-07-13 |
| 586 | 110.0608/CON.2026.00582 | Economic Evaluation Results Are Substantially Affected by Parameter Input Correlation |
Article | Public | 2026-07-13 | 2026-07-13 |
| 587 | 110.0607/CON.2026.00581 | Potential Impact of EQ-5D-5L Mapping Function Recently Recommended by the National Institute for Health and Care Excellence on Utility Values and Decision Making |
Article | Public | 2026-07-13 | 2026-07-13 |
| 588 | 110.0606/CON.2026.00580 | Health Impact and Cost-Effectiveness of Testing and Treatment of Mycobacterium Tuberculosis Infection Among Asian and Hispanic Persons With Diagnosed Diabetes in the United States |
Article | Public | 2026-07-13 | 2026-07-13 |
| 589 | 110.0605/CON.2026.00579 | First-Line Alectinib, Brigatinib, and Lorlatinib for Advanced Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: A Cost-Effectiveness Analysis |
Article | Public | 2026-07-13 | 2026-07-13 |
| 590 | 110.0604/CON.2026.00578 | Cost-Effectiveness of Enfortumab Vedotin and Pembrolizumab for First-Line Metastatic Urothelial Cancer in the United States |
Article | Public | 2026-07-13 | 2026-07-13 |
| 591 | 110.0603/CON.2026.00577 | Cost-Utility Analysis of Durvalumab and Tremelimumab Versus Best Supportive Care in Refractory Metastatic Colorectal Cancer |
Article | Public | 2026-07-13 | 2026-07-13 |
| 592 | 110.0602/CON.2026.00576 | The Argument-Based Approach to Validity Applied to Clinical Outcome Assessments: Some History and Notable Features |
Article | Public | 2026-07-13 | 2026-07-13 |
| 593 | 110.0601/CON.2026.00575 | R Packages for Matching-Adjusted Indirect Comparison: Differences in Usability and Identical Results From Reuse of Prior Code |
Article | Public | 2026-07-13 | 2026-07-13 |
| 594 | 110.0600/CON.2026.00574 | Quantifying the Impact of Intervention on Health Outcomes: A Tool for Assessing Incremental Changes to Life Expectancy |
Article | Public | 2026-07-13 | 2026-07-13 |
| 595 | 110.0599/CON.2026.00573 | Research Method, Conduct, and Reporting Considerations for Improving the Quality of Non-Hypothesis-Evaluating Treatment Effectiveness Analyses Using Real-World Data: An ISPOR Working Group Report |
Article | Public | 2026-07-10 | 2026-07-13 |
| 596 | 110.0598/CON.2026.00572 | Screening for Type 2 Diabetes Mellitus: A Systematic Review of Recent Economic Evaluations |
Article | Public | 2026-07-09 | 2026-07-10 |
| 597 | 110.0597/CON.2026.00571 | Economic Evaluation of Internet-Based Psychological Interventions: A Scoping Review of Methodological Choices |
Article | Public | 2026-07-09 | 2026-07-09 |
| 598 | 110.0596/CON.2026.00570 | Economic Evaluation of Internet-Based Psychological Interventions: A Scoping Review of Methodological Choices |
Article | Public | 2026-07-09 | 2026-07-09 |
| 599 | 110.0595/CON.2026.00569 | Can Adolescents Value the EQ-5D-Y-5L and EQ-5D-5L, and How Do the Values Compare? A Feasibility Study |
Article | Public | 2026-07-09 | 2026-07-09 |
| 600 | 110.0594/CON.2026.00568 | The New Dutch Guideline for Economic Evaluations in Healthcare: Taking the Societal Perspective to the Next Level |
Article | Public | 2026-07-09 | 2026-07-09 |